Daniel Delubac retweeted
🎙️iOrganBio CEO @DanielDelubac was recently interviewed on the Drug Digest Podcast to discuss the future of biopharma discovery and the necessity of strong partnerships that address the key challenges of drug discovery and development spanning in vitro modeling, clinical translation, and scale-up.
Talking with @PharmTechGroup Science Editor Feliza Mirasol, Delubac shared a wide range of insights into the drug discovery partnering ecosystem including:
🏭 How strategic outsourcing partnerships improve biopharma efficiency and scale
🚨 The ways in which partnerships reduce risks during early clinical development
🧬 How external expertise accelerates development for advanced and next gen therapies
🤝 What factors sponsors and drug developers consider when evaluating partners
iOrganBio is proud to be part of a thriving ecosystem of biotechnology and biopharma partners who are driving forward progress on life changing advanced therapies. Cells are a central component of this mission of therapeutic innovation, and with our CellDiscovery™ and CellForge™ platforms, iOB is accelerating progress by providing The Right Cells, Consistently, At Scale.
🎧 Catch the whole episode at pharmtech.com/view/drug-dige…
🌐 Learn more about iOrganBio at iorgan.bio
#DrugDiscovery #DrugDevelopment #Biopharma #NAMs
Yet another sign of the emergency to dramatically alter our western/US model for technical development. The cumulative gap in capability built over the past 10 years is now astronomical. We cannot catch up by simply learning from China, we have to come up with the next iteration
Daniel Delubac retweeted
Our very own @DanielDelubac will be presenting at #BioFuture next week as part of an all-star panel discussing the expanding role of organoids in drug discovery and development.
#Organoids #biotech #AdvancedTherapies
